Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 14:30:00 29/10/2026 HKT			5-day change	1st Jan Change
2,440.00 ^JPY	+1.04%		+2.87%	+0.37%

10-05	Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL	MT
07-01	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	423,624	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-7.78%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	423,624	423,624	423,624
Change	-	11%	26.5%	2.46%	24.61%	40.3%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	18.2x	15.4x	16x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.85x	0.81x	0.81x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-3.93x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.13x	0.13x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.13x	0.13x
EV / EBITDA	0x	0x	0x	0x	0x	8.21x	8.11x	8.07x
EV / EBIT	0x	0x	0x	0x	0x	12.3x	11.5x	11.1x
EV / FCF	0x	-0x	0x	-0x	0x	20.2x	25.9x	35.3x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	4.96%	3.86%	2.83%
Dividend per Share ²	54	57	70	63	68	71	79.67	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	2.94%	3.3%	3.52%
EPS ²	153.6	127.4	154.1	147.5	229.6	132.4	157	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	53.6%	50.8%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,193,819	3,288,778	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,628	52,221	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,398	36,942	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,414	27,149	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,415.00	2,415.00	2,415.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	16/5/22	15/5/23	14/5/24	15/5/25	15/5/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALFRESA HOLDINGS CORPORATION	18.25x	-	-	2.94%	2.68B
ABBOTT LABORATORIES	33.95x	4.03x	15.12x	2.53%	178B
STRYKER CORPORATION	23.66x	4.63x	16.25x	1.18%	117B
MEDTRONIC PLC	20.38x	3.52x	12.6x	2.99%	116B
ESSILORLUXOTTICA	31.19x	3.01x	12.15x	2.29%	91.03B
CENCORA, INC.	17.79x	0.21x	12.9x	0.73%	61.89B
HOYA CORPORATION	31.8x	7.97x	20.49x	1.24%	55.85B
BECTON, DICKINSON AND COMPANY	38.71x	3.58x	12.19x	2.14%	53.16B
IDEXX LABORATORIES, INC.	38.13x	9.47x	26.48x	-.--%	44.35B
ALCON INC.	40.31x	3.26x	12.12x	0.53%	33.59B
Average	29.42x	4.41x	15.59x	1.66%	75.28B
Weighted average by Cap.	29.25x	4.15x	15.09x	1.85%